4 sources checked · Left, Center, and Right included · 1h ago
Different Spin
An m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Scientific American and The Washington Times describe the same event in different terms.
2 Left1 Center1 Right
Same story. Different framing.Left, center, and right outlets are covering the same event. Here’s how each side worded it.
DIFFERENT SPIN
HOW EACH SIDE WORDED IT
Left-leaningCenter-leftA Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%TimeHigh
vs
Right-leaningCenter-rightA novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returningThe Washington TimesMixed
Center baseline · WDSU New Orleans (Hearst)HighAn m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
As of October 22, 2026 at 11:54 PM, this is how Optics News reads the wording differences in this story.
What happenedA first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
The headline splitThe left frames it as "A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%". The right frames it as "A novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors return...".
Match confidenceHigh confidence. 4 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceMedium
4 sources across 3 bias buckets agree on the event.
Framing confidenceModerate
73/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftA Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
Time · Center-left · News report
CenterAn m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
WDSU New Orleans (Hearst) · Center · News report
Right / center-rightA novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Mode...
